Kerala Ayurveda

  • Market Cap: Micro Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE817B01025
  • NSEID:
  • BSEID: 530163
INR
242.55
14.45 (6.33%)
BSENSE

Feb 03

BSE+NSE Vol: 45.66 k

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy

MarketsMojo — Loved in India, Now Global

The power of Mojo is now in 29 countries. Explore global equities with the same cutting-edge features you love.

Comparison

Company
Score
Quality
Valuation
Financial
Technical
Haleos Labs Limi
Trident Lifeline
Zenotech Lab.
Bafna Pharma.
Gennex Lab.
Valiant Laborato
Nectar Lifesci.
Kerala Ayurveda
Lyka Labs
Infinium Pharma
Sat Kartar

Why is Kerala Ayurveda Ltd ?

1
With HIgh Debt (Debt-Equity Ratio at 14.59 times)- the company has a Weak Long Term Fundamental Strength
  • Poor long term growth as Operating profit has grown by an annual rate 0% of over the last 5 years
  • High Debt Company with a Debt to Equity ratio (avg) at 0 times
  • The company has been able to generate a Return on Capital Employed (avg) of 6.09% signifying low profitability per unit of total capital (equity and debt)
2
The company has declared Negative results for the last 3 consecutive quarters
  • PBT LESS OI(Q) At Rs -8.52 cr has Fallen at -64.6% (vs previous 4Q average)
  • PAT(Q) At Rs -6.34 cr has Fallen at -94.8% (vs previous 4Q average)
  • ROCE(HY) Lowest at -15.13%
3
Risky - Negative EBITDA
  • The stock is trading risky as compared to its average historical valuations
  • Over the past year, while the stock has generated a return of -38.59%, its profits have fallen by -743.5%
4
Underperformed the market in the last 1 year
  • Even though the market (BSE500) has generated returns of 9.12% in the last 1 year, the stock has hugely underperformed and has generate negative returns of -38.59% returns
stock-recommendationReal-Time Research Report

Verdict Report

How much should you sell?

  1. All quantity irrespective of whether you are making profits or losses

(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)

When to re-enter? - We will constantly monitor the company and review our call based on new data

Is Kerala Ayurveda for you?

High Risk, Low Return

Absolute
Risk Adjusted
Volatility
Kerala Ayurveda
-38.59%
-0.70
55.39%
Sensex
8.49%
0.74
11.41%
stock-recommendationQuality
stock-summaryManagement Risk
stock-summaryGrowth
stock-summaryCapital Structure
stock-recommendation
Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors

Factor
Value
Sales Growth (5y)
14.84%
EBIT Growth (5y)
-251.28%
EBIT to Interest (avg)
0.07
Debt to EBITDA (avg)
15.24
Net Debt to Equity (avg)
14.59
Sales to Capital Employed (avg)
1.13
Tax Ratio
14.15%
Dividend Payout Ratio
0
Pledged Shares
23.56%
Institutional Holding
0.26%
ROCE (avg)
0.62%
ROE (avg)
0
stock-recommendationValuation

Valuation Scorecard stock-summary

stock-recommendation
Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors stock-summary

Factor
Value
P/E Ratio
NA (Loss Making)
Industry P/E
32
Price to Book Value
53.58
EV to EBIT
-14.45
EV to EBITDA
-18.18
EV to Capital Employed
4.37
EV to Sales
2.96
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
-30.26%
ROE (Latest)
-417.22%
Loading Valuation Snapshot...
stock-recommendationTechnicals

Technical key factors

Indicator
Weekly
Monthly
MACD
Bearish
Mildly Bearish
RSI
Bullish
No Signal
Bollinger Bands
Bearish
Bearish
Moving Averages
Bearish (Daily)
KST
Bearish
Mildly Bearish
Dow Theory
Mildly Bearish
Mildly Bearish
stock-recommendation Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
Technical Movement
stock-recommendationFinancial Trend

Financial Trend Scorecard stock-summary

stock-recommendation
Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

2What is working for the Company
DEBTORS TURNOVER RATIO(HY)

Highest at 7.77 times

NET SALES(Q)

Highest at Rs 34.84 cr

-19What is not working for the Company
PBT LESS OI(Q)

At Rs -8.52 cr has Fallen at -64.6% (vs previous 4Q average

PAT(Q)

At Rs -6.34 cr has Fallen at -94.8% (vs previous 4Q average

ROCE(HY)

Lowest at -15.13%

DEBT-EQUITY RATIO(HY)

Highest at 15.49 times

INTEREST(Q)

Highest at Rs 2.58 cr

Loading Valuation Snapshot...

Here's what is working for Kerala Ayurveda

Net Sales - Quarterly
Highest at Rs 34.84 cr
in the last five quarters
MOJO Watch
Near term sales trend is positive

Net Sales (Rs Cr)

Debtors Turnover Ratio- Half Yearly
Highest at 7.77 times
in the last five half yearly periods
MOJO Watch
Company has been able to settle its Debtors faster

Debtors Turnover Ratio

Here's what is not working for Kerala Ayurveda

Profit Before Tax less Other Income (PBT) - Quarterly
At Rs -8.52 cr has Fallen at -64.6% (vs previous 4Q average)
over average PBT of the previous four quarters of Rs -5.18 Cr
MOJO Watch
Near term PBT trend is very negative

PBT less Other Income (Rs Cr)

Profit After Tax (PAT) - Quarterly
At Rs -6.34 cr has Fallen at -94.8% (vs previous 4Q average)
over average PAT of the previous four quarters of Rs -3.26 Cr
MOJO Watch
Near term PAT trend is very negative

PAT (Rs Cr)

Interest - Quarterly
At Rs 2.58 cr has Grown at 257,999,900.00%
Quarter on Quarter (QoQ)
MOJO Watch
Rising interest cost signifies increased borrowings

Interest Paid (Rs cr)

Interest - Quarterly
Highest at Rs 2.58 cr
in the last five quarters and Increased by 257,999,900.00 % (QoQ)
MOJO Watch
Rising interest cost signifies increased borrowings

Interest Paid (Rs cr)

Debt-Equity Ratio - Half Yearly
Highest at 15.49 times
in the last five half yearly periods
MOJO Watch
The company is borrowing more to fund its operations; it's liquidity situation may be stressed

Debt-Equity Ratio